Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Nicole Gonzales

Concepts (309)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cerebral Hemorrhage
27
2024
120
4.300
Why?
Stroke
39
2025
1260
3.310
Why?
Neurology
6
2026
114
2.400
Why?
Tissue Plasminogen Activator
23
2024
244
2.050
Why?
Brain Ischemia
19
2025
358
1.710
Why?
Fibrinolytic Agents
17
2024
293
1.540
Why?
Thrombolytic Therapy
14
2024
163
1.400
Why?
Sexism
1
2024
70
0.790
Why?
Hematoma
6
2015
59
0.770
Why?
Ischemic Attack, Transient
1
2023
71
0.750
Why?
Endarterectomy, Carotid
4
2015
60
0.690
Why?
Education, Medical
1
2024
276
0.650
Why?
Platelet Aggregation Inhibitors
3
2022
498
0.640
Why?
Carotid Stenosis
4
2014
102
0.630
Why?
Women
1
2020
50
0.630
Why?
Decompressive Craniectomy
1
2019
9
0.610
Why?
Medicine
1
2020
125
0.570
Why?
Matrix Metalloproteinases
1
2019
98
0.560
Why?
Time-to-Treatment
2
2021
245
0.550
Why?
Stents
5
2015
557
0.540
Why?
Mobile Health Units
3
2024
20
0.520
Why?
Percutaneous Coronary Intervention
1
2022
547
0.500
Why?
Angioplasty
2
2014
50
0.490
Why?
Attention
1
2020
458
0.490
Why?
Brain Injuries
1
2020
508
0.430
Why?
Cerebral Revascularization
1
2014
22
0.430
Why?
Aged
39
2024
26001
0.400
Why?
Emergency Medical Services
5
2024
697
0.400
Why?
Humans
70
2026
145307
0.400
Why?
Diffusion Tensor Imaging
2
2024
73
0.390
Why?
Treatment Outcome
28
2023
11731
0.380
Why?
Middle Aged
42
2025
36021
0.380
Why?
Cerebral Ventricles
3
2024
54
0.380
Why?
Hypertension
3
2016
1266
0.360
Why?
Thiazolidinediones
2
2012
139
0.350
Why?
Female
48
2026
78605
0.320
Why?
Health Education
4
2023
358
0.310
Why?
Male
49
2025
72629
0.310
Why?
Disability Evaluation
3
2021
310
0.300
Why?
Clinical Trials as Topic
6
2023
1063
0.280
Why?
Prospective Studies
14
2024
8011
0.280
Why?
Aged, 80 and over
19
2024
8295
0.260
Why?
Schools
2
2007
453
0.250
Why?
Time Factors
12
2025
7186
0.240
Why?
Risk Factors
10
2025
10816
0.230
Why?
Awareness
1
2007
110
0.230
Why?
Demyelinating Autoimmune Diseases, CNS
1
2005
4
0.230
Why?
Paraneoplastic Syndromes, Nervous System
1
2005
14
0.230
Why?
Encephalomyelitis, Acute Disseminated
1
2005
11
0.230
Why?
Lactation
1
2026
192
0.220
Why?
Cerebral Intraventricular Hemorrhage
1
2024
4
0.220
Why?
Cerebral Blood Volume
1
2024
5
0.220
Why?
Anticoagulants
3
2019
726
0.210
Why?
Healthcare Disparities
2
2024
736
0.200
Why?
Workplace
1
2026
274
0.200
Why?
American Heart Association
2
2023
356
0.200
Why?
Skin Diseases, Vesiculobullous
1
2003
17
0.200
Why?
Herpesvirus 2, Human
1
2003
27
0.200
Why?
Encephalitis, Herpes Simplex
1
2003
21
0.200
Why?
Pyramidal Tracts
1
2023
30
0.190
Why?
Cytochrome P-450 CYP2C19
1
2022
26
0.190
Why?
Antihypertensive Agents
3
2016
513
0.190
Why?
Ambulances
2
2021
53
0.190
Why?
Pilot Projects
5
2023
1894
0.180
Why?
Academic Medical Centers
2
2024
548
0.180
Why?
Hypoglycemic Agents
1
2012
1391
0.180
Why?
Heterozygote
1
2022
315
0.180
Why?
Postoperative Complications
1
2014
2938
0.180
Why?
Health Status Disparities
1
2025
322
0.180
Why?
PPAR gamma
3
2014
177
0.170
Why?
Databases, Factual
3
2019
1488
0.170
Why?
Adult
19
2025
40627
0.170
Why?
Prognosis
6
2025
4310
0.170
Why?
Retrospective Studies
16
2025
17149
0.170
Why?
Neuroprotective Agents
2
2015
143
0.170
Why?
Health Promotion
2
2007
777
0.170
Why?
Faculty, Medical
1
2024
303
0.160
Why?
Sex Factors
4
2025
2115
0.160
Why?
Anxiety Disorders
1
2023
373
0.160
Why?
United States
10
2024
16051
0.150
Why?
Factor VIIa
2
2011
43
0.150
Why?
Pipecolic Acids
2
2012
24
0.150
Why?
Aspirin
1
2022
401
0.150
Why?
Schools, Medical
1
2020
157
0.150
Why?
Inpatients
1
2024
551
0.150
Why?
Predictive Value of Tests
4
2019
2118
0.150
Why?
Recovery of Function
3
2019
714
0.140
Why?
Overweight
1
2023
610
0.140
Why?
Edema
1
2019
124
0.140
Why?
Isoenzymes
1
2019
299
0.140
Why?
Health Services Needs and Demand
1
2020
281
0.140
Why?
Glasgow Coma Scale
1
2019
221
0.140
Why?
Adenocarcinoma
1
2005
931
0.130
Why?
Dose-Response Relationship, Drug
4
2012
2032
0.130
Why?
Disease Progression
3
2013
2855
0.130
Why?
Genotype
1
2022
1845
0.130
Why?
Mexican Americans
2
2009
119
0.130
Why?
NF-E2-Related Factor 2
2
2015
95
0.130
Why?
Propensity Score
1
2019
370
0.130
Why?
Communication
1
2024
973
0.130
Why?
Injury Severity Score
1
2019
605
0.120
Why?
Hospital Mortality
2
2019
1035
0.120
Why?
Platelet Transfusion
1
2017
80
0.120
Why?
Severity of Illness Index
8
2024
2926
0.120
Why?
Ultrasonography, Doppler, Transcranial
3
2013
48
0.120
Why?
Decision Making
1
2023
980
0.120
Why?
Anxiety
1
2023
1113
0.120
Why?
Tomography, X-Ray Computed
4
2021
2745
0.110
Why?
Texas
4
2013
278
0.110
Why?
Fumarates
1
2015
10
0.110
Why?
Microglia
2
2008
269
0.110
Why?
Quality of Health Care
1
2020
696
0.110
Why?
Pneumonia, Viral
1
2020
386
0.110
Why?
Anti-Inflammatory Agents
2
2011
475
0.110
Why?
Coronavirus Infections
1
2020
380
0.110
Why?
Retinoid X Receptors
1
2014
38
0.110
Why?
Antithrombins
2
2013
70
0.110
Why?
Recombinant Proteins
4
2011
1371
0.110
Why?
Blood Pressure
3
2011
1771
0.110
Why?
Risk Assessment
2
2025
3686
0.100
Why?
Intraoperative Complications
1
2015
158
0.100
Why?
Cerebral Infarction
1
2014
47
0.100
Why?
Neutrophil Infiltration
1
2014
104
0.100
Why?
Single-Blind Method
1
2014
319
0.100
Why?
Cohort Studies
7
2022
5982
0.100
Why?
Odds Ratio
3
2021
1077
0.100
Why?
Follow-Up Studies
4
2017
5431
0.100
Why?
Perioperative Care
1
2015
232
0.100
Why?
Delivery of Health Care
1
2020
947
0.100
Why?
Quality Control
1
2013
163
0.100
Why?
Registries
3
2025
2398
0.090
Why?
Genetic Predisposition to Disease
1
2021
2371
0.090
Why?
Medical Records
1
2013
190
0.090
Why?
Sulfonamides
3
2012
581
0.090
Why?
Biomarkers
2
2019
4284
0.090
Why?
Lung Neoplasms
1
2005
2652
0.090
Why?
Surveys and Questionnaires
2
2026
6079
0.090
Why?
Carotid Artery, Internal
1
2011
45
0.090
Why?
Telemedicine
2
2020
957
0.090
Why?
Cyclooxygenase 2 Inhibitors
1
2011
23
0.090
Why?
Cerebral Amyloid Angiopathy
1
2011
9
0.090
Why?
Celecoxib
1
2011
41
0.090
Why?
Collagen Type IV
1
2011
28
0.090
Why?
Neurosurgical Procedures
1
2013
202
0.090
Why?
Exercise
1
2023
2206
0.080
Why?
Nervous System Diseases
1
2014
284
0.080
Why?
Brain Edema
1
2011
62
0.080
Why?
Carotid Arteries
1
2012
207
0.080
Why?
History, 20th Century
1
2012
327
0.080
Why?
NF-kappa B
1
2014
662
0.080
Why?
Universities
1
2013
453
0.080
Why?
Injections, Intra-Arterial
4
2013
26
0.080
Why?
Nephrology
1
2011
60
0.080
Why?
Platelet Glycoprotein GPIIb-IIIa Complex
1
2009
26
0.080
Why?
Double-Blind Method
2
2012
2033
0.080
Why?
Treatment Failure
2
2014
365
0.080
Why?
Heparin
1
2011
244
0.070
Why?
Health Care Surveys
1
2011
539
0.070
Why?
Resuscitation Orders
1
2009
48
0.070
Why?
Research Design
2
2013
1137
0.070
Why?
Hand Transplantation
1
2008
9
0.070
Why?
Intracranial Thrombosis
1
2008
19
0.070
Why?
Venous Thrombosis
1
2011
195
0.070
Why?
Caffeine
1
2009
74
0.070
Why?
Hand Injuries
1
2008
33
0.070
Why?
Endovascular Procedures
1
2013
385
0.070
Why?
Adolescent
8
2025
22507
0.070
Why?
Neutrophils
1
2014
1135
0.070
Why?
Embolism
1
2008
48
0.070
Why?
Hypothermia, Induced
1
2009
96
0.070
Why?
Pyrazoles
1
2011
510
0.060
Why?
Quality Improvement
1
2016
1296
0.060
Why?
Practice Patterns, Physicians'
2
2017
1358
0.060
Why?
Renal Dialysis
1
2011
465
0.060
Why?
Nerve Fibers, Myelinated
1
2005
47
0.060
Why?
Organ Transplantation
1
2008
248
0.060
Why?
Methylprednisolone
1
2005
64
0.060
Why?
Emergency Treatment
1
2006
124
0.050
Why?
Teaching
1
2007
240
0.050
Why?
Heart Diseases
1
2008
350
0.050
Why?
Kidney Failure, Chronic
1
2011
598
0.050
Why?
Paralysis
1
2005
67
0.050
Why?
Brain Stem
1
2005
96
0.050
Why?
Muscle Weakness
1
2005
92
0.050
Why?
Phagocytosis
3
2014
299
0.050
Why?
Injections, Intravenous
3
2011
200
0.050
Why?
Fatal Outcome
1
2005
307
0.050
Why?
Program Development
1
2007
370
0.050
Why?
Quality-Adjusted Life Years
1
2024
122
0.050
Why?
Administration, Intravenous
2
2017
170
0.050
Why?
Young Adult
3
2025
14163
0.050
Why?
Case-Control Studies
3
2021
3613
0.050
Why?
Ethanol
1
2009
627
0.050
Why?
Diffusion Magnetic Resonance Imaging
1
2005
154
0.050
Why?
Emergency Service, Hospital
1
2016
2329
0.050
Why?
Chi-Square Distribution
2
2017
529
0.050
Why?
Peptides
1
2009
999
0.050
Why?
Meningitis, Aseptic
1
2003
13
0.050
Why?
Growth and Development
1
2023
9
0.050
Why?
Principal Component Analysis
1
2023
198
0.050
Why?
Hemorrhage
2
2023
810
0.050
Why?
Spinal Cord
1
2005
383
0.050
Why?
Headache
1
2003
150
0.040
Why?
Catalase
2
2014
130
0.040
Why?
Age Factors
2
2025
3339
0.040
Why?
Acute Disease
3
2011
1031
0.040
Why?
Students
1
2007
663
0.040
Why?
Cost-Benefit Analysis
1
2024
639
0.040
Why?
Certification
1
2023
121
0.040
Why?
Respiratory Insufficiency
1
2005
328
0.040
Why?
Partial Thromboplastin Time
2
2012
50
0.040
Why?
Brain
1
2014
2945
0.040
Why?
Reperfusion
2
2013
54
0.040
Why?
DNA, Viral
1
2003
358
0.040
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2003
983
0.040
Why?
Macrophages
1
2008
1514
0.040
Why?
Practice Guidelines as Topic
3
2017
1568
0.040
Why?
Hospital Bed Capacity
1
2020
28
0.040
Why?
Guideline Adherence
2
2017
589
0.040
Why?
Health Care Rationing
1
2020
60
0.040
Why?
Ethics, Medical
1
2020
90
0.040
Why?
Kaplan-Meier Estimate
2
2012
967
0.040
Why?
Rats, Sprague-Dawley
2
2015
2541
0.040
Why?
Health Resources
1
2020
131
0.040
Why?
Magnetic Resonance Imaging
3
2023
3888
0.040
Why?
Caregivers
1
2007
1056
0.030
Why?
Logistic Models
2
2017
2119
0.030
Why?
Incidence
1
2025
2892
0.030
Why?
CD36 Antigens
2
2008
32
0.030
Why?
Combined Modality Therapy
2
2013
1268
0.030
Why?
Hospitals
1
2023
733
0.030
Why?
Arginine
2
2012
262
0.030
Why?
Autoantibodies
1
2005
1510
0.030
Why?
Ventriculostomy
1
2017
24
0.030
Why?
Betacoronavirus
1
2020
285
0.030
Why?
Drug Therapy, Combination
2
2012
1048
0.030
Why?
Statistics, Nonparametric
1
2017
427
0.030
Why?
Rats
2
2015
5616
0.030
Why?
Longitudinal Studies
1
2023
2959
0.030
Why?
Dimethyl Fumarate
1
2015
12
0.030
Why?
Thrombocytopenia
1
2017
205
0.030
Why?
Disease Models, Animal
3
2014
4580
0.030
Why?
Body Mass Index
1
2023
2439
0.030
Why?
Neuroimmunomodulation
1
2014
68
0.030
Why?
Perfusion Imaging
1
2014
65
0.030
Why?
Intensive Care Units
1
2020
916
0.030
Why?
Multivariate Analysis
1
2017
1540
0.020
Why?
Biomedical Research
1
2020
713
0.020
Why?
Sex Distribution
1
2014
386
0.020
Why?
Animals
5
2015
38180
0.020
Why?
Tomography Scanners, X-Ray Computed
1
2012
21
0.020
Why?
Cerebral Veins
1
2012
16
0.020
Why?
Erythrocytes
2
2008
757
0.020
Why?
Health Services Accessibility
1
2020
1104
0.020
Why?
Cerebral Arteries
1
2012
58
0.020
Why?
Pandemics
1
2020
1698
0.020
Why?
Plasminogen Activators
1
2011
7
0.020
Why?
Heparin, Low-Molecular-Weight
1
2011
36
0.020
Why?
Radiography
1
2013
846
0.020
Why?
Quality of Life
1
2023
3197
0.020
Why?
Mice, Inbred C57BL
2
2015
6009
0.020
Why?
Analysis of Variance
1
2013
1311
0.020
Why?
Magnetic Resonance Angiography
1
2012
251
0.020
Why?
Obesity
1
2023
3085
0.020
Why?
Length of Stay
1
2015
1342
0.020
Why?
Buspirone
1
2009
5
0.020
Why?
Meperidine
1
2009
6
0.020
Why?
Shivering
1
2009
5
0.020
Why?
Life Support Care
1
2009
42
0.020
Why?
Adjuvants, Anesthesia
1
2009
13
0.020
Why?
Microspheres
1
2009
142
0.020
Why?
Mice
3
2015
18397
0.020
Why?
Microcirculation
1
2009
145
0.020
Why?
Brain Damage, Chronic
1
2008
18
0.020
Why?
Anti-Anxiety Agents
1
2009
47
0.020
Why?
Infusions, Intra-Arterial
1
2008
61
0.020
Why?
Cerebral Angiography
1
2008
119
0.020
Why?
Mice, Knockout
1
2015
3129
0.020
Why?
Blood Flow Velocity
1
2009
421
0.020
Why?
Behavior
1
2008
91
0.020
Why?
Drug Combinations
1
2009
392
0.020
Why?
Infusions, Intravenous
1
2008
423
0.020
Why?
Enzyme Activators
1
2007
9
0.020
Why?
Cultural Competency
1
2008
93
0.020
Why?
Prostaglandin D2
1
2007
22
0.020
Why?
Regression Analysis
1
2009
1003
0.020
Why?
Urokinase-Type Plasminogen Activator
1
2006
24
0.020
Why?
Nitric Oxide Synthase Type II
1
2007
162
0.020
Why?
Deep Brain Stimulation
1
2009
213
0.010
Why?
Graft Survival
1
2008
528
0.010
Why?
Hydrogen Peroxide
1
2007
336
0.010
Why?
Reproducibility of Results
1
2013
3419
0.010
Why?
Graft Rejection
1
2008
542
0.010
Why?
Recurrence
1
2008
1138
0.010
Why?
Urban Population
1
2008
495
0.010
Why?
Animals, Newborn
1
2007
898
0.010
Why?
Self Efficacy
1
2008
414
0.010
Why?
Recombinant Fusion Proteins
1
2006
675
0.010
Why?
Myocardial Infarction
1
2011
1211
0.010
Why?
Program Evaluation
1
2007
949
0.010
Why?
Atrial Fibrillation
1
2008
552
0.010
Why?
Curriculum
1
2007
1072
0.010
Why?
Apoptosis
1
2008
2430
0.010
Why?
Cells, Cultured
1
2007
4156
0.010
Why?
Cytokines
1
2007
2066
0.010
Why?
Parents
1
2007
1404
0.010
Why?
Health Knowledge, Attitudes, Practice
1
2007
1420
0.010
Why?
Neurons
1
2007
1642
0.010
Why?
Child
1
2007
22712
0.000
Why?
Gonzales's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)